The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Emerging roles of SIRT1 in fatty liver diseases
Open accessAbstract
Fatty liver diseases, which are commonly associated with high-fat/calorie diet, heavy alcohol consumption and/or other metabolic disorder causes, lead to serious medical concerns worldwide in recent years.It has been demonstrated that metabolic homeostasis disruption is most likely to be responsible for this global epidemic.Sirtuins are a group of conserved nicotinamide adenine dinucleotide (NAD + ) dependent histone and/or protein deacetylases belonging to the silent information regulator 2 (Sir2) family.Among seven mammalian sirtuins, sirtuin 1 (SIRT 1) is the most extensively studied one and is involved in both alcoholic and nonalcoholic fatty liver diseases.SIRT1 plays beneficial roles in regulating hepatic lipid metabolism, controlling hepatic oxidative stress and mediating hepatic inflammation through deacetylating some transcriptional regulators against the progression of fatty liver diseases.Here we summarize the latest advances of the biological roles of SIRT1 in regulating lipid metabolism, oxidative stress and inflammation in the liver, and discuss the potential of SIRT1 as a therapeutic target for treating alcoholic and nonalcoholic fatty liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sodhi, K., Puri, N., Favero, G., Stevens, S., Meadows, C., Abraham, N. G., Rezzani, R., Ansinelli, H. A., Lebovics, E., & Shapiro, J. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128648 · Cited by 70
RetractedTHE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 7×
“Under high-fat diet, dietary fats taken up in the intestine are delivered into blood circulation as TG-rich chylomicrons and free fatty acids (FFA), and about 20% of them are delivered into the liver by hepatic lipid uptake [35, 37].”
BackgroundInfluentialSirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Sirtuins in mammals: insights into their biological function
Michan, S., & Sinclair, D. (2007) · Biochemical Journal · doi:10.1042/bj20070140 · Cited by 1,718
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707 · cited 2×
“However, cautious evaluation on these newly developed SIRT1 agonists are still necessary to avoid any un-wanted side effects, especially for those later developed ones with 800-1000-fold more potency than resveratrol in activating SIRT1 [132].”
BackgroundExtrachromosomal rDNA circles—a cause of aging in yeast
Sinclair, D. A., & Guarente, L. (1997) · Cell · doi:10.1016/s0092-8674(00)80493-6 · Cited by 1,500
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
Self-citationCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome
Zhang, J., Bottiglieri, T., & McCullough, P. A. (2017) · Cardiorenal Medicine · doi:10.1159/000452283 · Cited by 1,080
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., & Li, X. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.006 · Cited by 1,003
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837
Sirt1 protects against high-fat diet-induced metabolic damage
Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M., & Tschöp, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802917105 · Cited by 818
Overview: how is alcohol metabolized by the body?
(2006) · PubMed Central · Cited by 813
Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
Wang, R.-H., Sengupta, K., Li, C., Kim, H.-S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.001 · Cited by 769
Self-citationAntioxidants and Oxidative Stress in Exercise
Ji, L. L. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-145.x · Cited by 728
Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c
Ferré, P., & Foufelle, F. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01275.x · Cited by 704
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
Transcriptional regulation via the NF-κB signaling module
Hoffmann, A., Natoli, G., & Ghosh, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209933 · Cited by 629
Tissue-specific regulation of SIRT1 by calorie restriction
Chen, D., Bruno, J., Easlon, E., Lin, S.-J., Cheng, H.-L., Alt, F. W., & Guarente, L. (2008) · Genes & Development · doi:10.1101/gad.1650608 · Cited by 567
Non alcoholic fatty liver disease and metabolic syndrome.
Paschos, P., & Paletas, K. (2009) · PubMed · Cited by 555
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, C. K., Northup, P. G., Al-Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 552
SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism*
Ponugoti, B., Kim, D.-H., Xiao, Z., Smith, Z., Miao, J., Zang, M., Wu, S.-Y., Chiang, C.-M., Veenstra, T. D., & Kemper, J. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.122978 · Cited by 543
FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2
van der Horst, A., Tertoolen, L. G. J., de Vries-Smits, L. M. M., Frye, R. A., Medema, R. H., & Burgering, B. M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401138200 · Cited by 543
Pathogenesis of Nonalcoholic Steatohepatitis
Machado, M. V., & Diehl, A. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.066 · Cited by 539
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Kim, H.-S., Vassilopoulos, A., Wang, R.-H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T. D., Li, B., Yu, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.004 · Cited by 537
Self-citationUyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 529
(2010) · doi:10.1016/j.cmet.2010.06.009 · Cited by 512
Self-citationFormation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons
Redgrave, T. G. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106255 · Cited by 497
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215593 · Cited by 480
Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1
Rodgers, J. T., & Puigserver, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702509104 · Cited by 466
Jeong, S. M., Xiao, C., Finley, L. W. S., Lahusen, T., Souza, A. L., Pierce, K., Li, Y.-H., Wang, X., Laurent, G., German, N. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.024 · Cited by 445
Self-citationResveratrol is not a direct activator of SIRT1 enzyme activity
Beher, D., Wu, J., Cumine, S., Kim, K. W., Lu, S., Atangan, L., & Wang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00901.x · Cited by 426
Genetic control of de novo lipogenesis: role in diet-induced obesity
Strable, M. S., & Ntambi, J. M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409231003667500 · Cited by 416
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation
Kendrick, A. A., Choudhury, M., Rahman, S. M., McCurdy, C. E., Friederich, M., Van Hove, J. L. K., Watson, P. A., Birdsey, N., Bao, J., Gius, D., et al. (2011) · Biochemical Journal · doi:10.1042/bj20100791 · Cited by 382
Self-citationGariani, K., Menzies, K. J., Ryu, D., Wegner, C. J., Wang, X., Ropelle, E. R., Moullan, N., Zhang, H., Perino, A., Lemos, V., et al. (2016) · Hepatology · doi:10.1002/hep.28245 · Cited by 368
Li, X. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms108 · Cited by 360
Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress
Hori, Y. S., Kuno, A., Hosoda, R., & Horio, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073875 · Cited by 358
Walker, A. K., Yang, F., Jiang, K., Ji, J.-Y., Watts, J. L., Purushotham, A., Boss, O., Hirsch, M. L., Ribich, S., Smith, J. J., et al. (2010) · Genes & Development · doi:10.1101/gad.1901210 · Cited by 357
Non-Alcoholic Fatty Liver Disease and the Metabolic Syndrome
Najjar, S. M. (2011) · Metabolic Basis of Obesity · doi:10.1007/978-1-4419-1607-5_12 · Cited by 354
Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis
Horton, J. D. (2002) · Biochemical Society Transactions · doi:10.1042/bst0301091 · Cited by 352
Faghihzadeh, F., Adibi, P., Rafiei, R., & Hekmatdoost, A. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.09.005 · Cited by 344
du Plessis, J., van Pelt, J., Korf, H., Mathieu, C., van der Schueren, B., Lannoo, M., Oyen, T., Topal, B., Fetter, G., Nayler, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.044 · Cited by 325
SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
Deng, C.-X. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.147 · Cited by 321
Self-citationMyeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress
Schug, T. T., Xu, Q., Gao, H., Peres-da-Silva, A., Draper, D. W., Fessler, M. B., Purushotham, A., & Li, X. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00657-10 · Cited by 320
Sirtuins Link Inflammation and Metabolism
Vachharajani, V. T., Liu, T., Wang, X., Hoth, J. J., Yoza, B. K., & McCall, C. E. (2016) · Journal of Immunology Research · doi:10.1155/2016/8167273 · Cited by 320
Chen, S., Zhao, X., Ran, L., Wan, J., Wang, X., Qin, Y., Shu, F., Gao, Y., Yuan, L., Zhang, Q., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.015 · Cited by 319
Wang, R.-H., Kim, H.-S., Xiao, C., Xu, X., Gavrilova, O., & Deng, C.-X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46243 · Cited by 314
Self-citationResveratrol alleviates alcoholic fatty liver in mice
Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., & You, M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90358.2008 · Cited by 314
Molecular Mechanisms of Alcoholic Fatty Liver
Purohit, V., Gao, B., & Song, B. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00827.x · Cited by 312
Rajamohan, S. B., Pillai, V. B., Gupta, M., Sundaresan, N. R., Birukov, K. G., Samant, S., Hottiger, M. O., & Gupta, M. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00121-09 · Cited by 302
Bricambert, J., Miranda, J., Benhamed, F., Girard, J., Postic, C., & Dentin, R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41624 · Cited by 300
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Chachay, V. S., Macdonald, G. A., Martin, J. H., Whitehead, J. P., O'Moore–Sullivan, T. M., Lee, P., Franklin, M., Klein, K., Taylor, P. J., Ferguson, M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.024 · Cited by 289
High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice
van der Heijden, R. A., Sheedfar, F., Morrison, M. C., Hommelberg, P. P., Kor, D., Kloosterhuis, N. J., Gruben, N., Youssef, S. A., de Bruin, A., Hofker, M. H., et al. (2015) · Aging · doi:10.18632/aging.100738 · Cited by 288
Li, Y., Wong, K., Giles, A., Jiang, J., Lee, J. W., Adams, A. C., Kharitonenkov, A., Yang, Q., Gao, B., Guarente, L., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.059 · Cited by 279
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
SHANG, J., CHEN, L.-L., XIAO, F.-X., SUN, H., DING, H.-C., & XIAO, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00807.x · Cited by 274
SirT1 regulates adipose tissue inflammation
Gillum, M. P., Kotas, M. E., Erion, D. M., Kursawe, R., Chatterjee, P., Nead, K. T., Muise, E. S., Hsiao, J. J., Frederick, D. W., Yonemitsu, S., et al. (2011) · Diabetes · doi:10.2337/db11-0616 · Cited by 260
Hong, S., Moreno-Navarrete, J. M., Wei, X., Kikukawa, Y., Tzameli, I., Prasad, D., Lee, Y., Asara, J. M., Fernandez-Real, J. M., Maratos-Flier, E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3882 · Cited by 257
Andrade, J. M. O., Paraíso, A. F., de Oliveira, M. V. M., Martins, A. M. E., Neto, J. F., Guimarães, A. L. S., de Paula, A. M., Qureshi, M., & Santos, S. H. S. (2014) · Nutrition · doi:10.1016/j.nut.2013.11.016 · Cited by 237
Negative regulation of inflammation by SIRT1
Xie, J., Zhang, X., & Zhang, L. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.010 · Cited by 234
Chronic Alcohol Exposure Stimulates Adipose Tissue Lipolysis in Mice
Zhong, W., Zhao, Y., Tang, Y., Wei, X., Shi, X., Sun, W., Sun, X., Yin, X., Sun, X., Kim, S., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.017 · Cited by 226
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Bujanda, L., Hijona, E., Larzabal, M., Beraza, M., Aldazabal, P., García-Urkia, N., Sarasqueta, C., Cosme, A., Irastorza, B., González, A., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-40 · Cited by 225
Xu, F., Gao, Z., Zhang, J., Rivera, C. A., Yin, J., Weng, J., & Ye, J. (2010) · Endocrinology · doi:10.1210/en.2009-1013 · Cited by 221
Pathogenesis of nonalcoholic steatohepatitis
Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2161-x · Cited by 221
Involvement of mammalian sirtuin 1 in the action of ethanol in the liver
You, M., Liang, X., Ajmo, J. M., & Ness, G. C. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00575.2007 · Cited by 214
Shen, Z., Liang, X., Rogers, C. Q., Rideout, D., & You, M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2009 · Cited by 214
Yin, H., Hu, M., Liang, X., Ajmo, J. M., Li, X., Bataller, R., Odena, G., Stevens, S. M., & You, M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.008 · Cited by 211
Novel insights into ChREBP regulation and function
Filhoulaud, G., Guilmeau, S., Dentin, R., Girard, J., & Postic, C. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.01.003 · Cited by 210
Molecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 209
Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
Kitada, M., Kume, S., Takeda-Watanabe, A., Kanasaki, K., & Koya, D. (2013) · Clinical Science · doi:10.1042/cs20120190 · Cited by 207
Coactivator-Dependent Acetylation Stabilizes Members of the SREBP Family of Transcription Factors
Giandomenico, V., Simonsson, M., Grünroos, E., & Ericsson, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2587-2599.2003 · Cited by 205
Hepatic NAD+ deficiency as a therapeutic target for non‐alcoholic fatty liver disease in ageing
Zhou, C., Yang, X., Hua, X., Liu, J., Fan, M., Li, G., Song, J., Xu, T., Li, Z., Guan, Y., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13513 · Cited by 199
Derdak, Z., Villegas, K. A., Harb, R., Wu, A. M., Sousa, A., & Wands, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.042 · Cited by 193
Mammalian Sirtuins and Energy Metabolism
Li, X., & Kazgan, N. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.575 · Cited by 192
Faghihzadeh, F., Adibi, P., & Hekmatdoost, A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002433 · Cited by 188 · cited 3×
“So, it is risky to apply SIRT1 activating drugs for fatty liver diseases treatment without organ specificity, which might explain why inconsistent results occurred in several fatty liver diseases related clinical trials with resveratrol treatment [140-144].”
BackgroundChen, J., Zhang, B., Wong, N., Lo, A. W. I., To, K.-F., Chan, A. W. H., Ng, M. H. L., Ho, C. Y. S., Cheng, S.-H., Lai, P. B. S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4274 · Cited by 188
Sirtuins in metabolism, DNA repair and cancer
Mei, Z., Zhang, X., Yi, J., Huang, J., He, J., & Tao, Y. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0461-5 · Cited by 186
Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression
Ramirez, T., Li, Y.-M., Yin, S., Xu, M.-J., Feng, D., Zhou, Z., Zang, M., Mukhopadhyay, P., Varga, Z. V., Pacher, P., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.004 · Cited by 185
SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL
Chakrabarti, P., English, T., Karki, S., Qiang, L., Tao, R., Kim, J., Luo, Z., Farmer, S. R., & Kandror, K. V. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014647 · Cited by 179
The expression of SIRT1 in nonalcoholic fatty liver disease induced by high‐fat diet in rats
Deng, X., Chen, L., & Li, N. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01497.x · Cited by 175
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
Ahn, J., Cho, I., Kim, S., Kwon, D., & Ha, T. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.012 · Cited by 173
Shen, Z., Ajmo, J. M., Rogers, C. Q., Liang, X., Le, L., Murr, M. M., Peng, Y., & You, M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00016.2009 · Cited by 172
Alcohol metabolism and epigenetics changes
Zakhari, S. (2013) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v35.1.02 · Cited by 169
Li, S., Liu, C., Li, N., Hao, T., Han, T., Hill, D. E., Vidal, M., & Lin, J. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.013 · Cited by 169
Mayoral, R., Osborn, O., McNelis, J., Johnson, A. M., Oh, D. Y., Izquierdo, C. L., Chung, H., Li, P., Traves, P. G., Bandyopadhyay, G., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.02.007 · Cited by 169
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis
Mukhopadhyay, P., Horváth, B., Rajesh, M., Varga, Z. V., Gariani, K., Ryu, D., Cao, Z., Holovac, E., Park, O., Zhou, Z., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.023 · Cited by 168
Gariani, K., Ryu, D., Menzies, K. J., Yi, H.-S., Stein, S., Zhang, H., Perino, A., Lemos, V., Katsyuba, E., Jha, P., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.024 · Cited by 167 · cited 4×
“The protective effects of Olaparib and other PAPR inhibitors against NAFLD and AFLD have been intensively reported during recent several months [135-138].”
BackgroundInfluentialSIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Colak, Y., Ozturk, O., Senates, E., Tuncer, I., Yorulmaz, E., Adali, G., Doganay, L., & Enc, F. Y. (2011) · Medical Science Monitor · doi:10.12659/msm.881749 · Cited by 165
Chen, H.-C., Jeng, Y.-M., Yuan, R.-H., Hsu, H.-C., & Chen, Y.-L. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2159-4 · Cited by 165
Tian, Y., Ma, J., Wang, W., Zhang, L., Xu, J., Wang, K., & Li, D. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2807-x · Cited by 162
Lee, J., Hong, S.-W., Chae, S. W., Kim, D. H., Choi, J. H., Bae, J. C., Park, S. E., Rhee, E.-J., Park, C.-Y., Oh, K.-W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031394 · Cited by 157
Heebøll, S., Kreuzfeldt, M., Hamilton-Dutoit, S., Kjær Poulsen, M., Stødkilde-Jørgensen, H., Møller, H. J., Jessen, N., Thorsen, K., Kristina Hellberg, Y., Bønløkke Pedersen, S., et al. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1107620 · Cited by 154
Xiao, C., Wang, R.-H., Lahusen, T. J., Park, O., Bertola, A., Maruyama, T., Reynolds, D. A., Chen, Q., Xu, X., Young, H. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415182 · Cited by 153
Self-citationLi, H., Xu, M., Lee, J., He, C., & Xie, Z. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00198.2012 · Cited by 147
Stanton, M. C., Chen, S., Jackson, J. V., Rojas-Triana, A., Kinsley, D., Cui, L., Fine, J. S., Greenfeder, S. A., Bober, L. A., & Jenh, C. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-8 · Cited by 145
Herbal medicines for the prevention of alcoholic liver disease: A review
Ding, R., Tian, K., huang, L.-L., He, C., Jiang, Y., Wang, Y., & Wan, J. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.09.044 · Cited by 141
Self-citationResveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
Yang, S. J., & Lim, Y. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.003 · Cited by 141
Wu, T., Liu, Y., Fu, Y., Liu, X., & Zhou, X.-H. (2014) · PubMed · Cited by 140
Yamazaki, Y., Usui, I., Kanatani, Y., Matsuya, Y., Tsuneyama, K., Fujisaka, S., Bukhari, A., Suzuki, H., Senda, S., Imanishi, S., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90997.2008 · Cited by 137
Chen, W.-L., Kang, C.-H., Wang, S.-G., & Lee, H.-M. (2012) · Diabetologia · doi:10.1007/s00125-012-2530-4 · Cited by 136
Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1α in rats
Lieber, C. S., Leo, M. A., Wang, X., & DeCarli, L. M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.005 · Cited by 135
Yang, Y., Li, W., Liu, Y., Sun, Y., Li, Y., Yao, Q., Li, J., Zhang, Q., Gao, Y., Gao, L., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.06.001 · Cited by 135
Sirtuin 1 signaling and alcoholic fatty liver disease.
You, M., Jogasuria, A. P., Taylor, C., & Wu, J. (2015) · PubMed · doi:10.3978/j.issn.2304-3881.2014.12.06 · Cited by 131
Sirtuins regulate key aspects of lipid metabolism
Lomb, D. J., Laurent, G., & Haigis, M. C. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.021 · Cited by 129
Sirtuins and nonalcoholic fatty liver disease
Nassir, F., & Ibdah, J. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i46.10084 · Cited by 129
Wang, R., Li, C., & Deng, C. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.682 · Cited by 126
Self-citationA Review of Sirt1 and Sirt1 Modulators in Cardiovascular and Metabolic Diseases
Pillarisetti, S. (2008) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489008786263989 · Cited by 121
Potential Modulation of Sirtuins by Oxidative Stress
Santos, L., Escande, C., & Denicola, A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9831825 · Cited by 121
Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models In Vitro and In Vivo
Portmann, S., Fahrner, R., Lechleiter, A., Keogh, A., Overney, S., Laemmle, A., Mikami, K., Montani, M., Tschan, M. P., Candinas, D., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0700 · Cited by 116
Redox-regulating sirtuins in aging, caloric restriction, and exercise
Radak, Z. O., Koltai, E., Taylor, A. W., Higuchi, M., Kumagai, S., Ohno, H., Goto, S., & Boldogh, I. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.004 · Cited by 115
Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism
Simmons, G. E., Jr., Pruitt, W. M., & Pruitt, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16010950 · Cited by 111
Santamarina, A. B., de Oliveira, J. L., da Silva, F. P., Carnier, J., Mennitti, L. V., de Santana, A. A., Gabriel, H. I. D. S., Ribeiro, E. B., do Nascimento, C. M. O., Lira, F. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141227 · Cited by 110
Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet
Alberdi, G., Rodríguez, V. M., Macarulla, M. T., Miranda, J., Churruca, I., & Portillo, M. P. (2012) · Nutrition · doi:10.1016/j.nut.2012.09.011 · Cited by 108
Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils
Ying, H., Liu, Y., Yu, B., Wang, Z., Zang, J.-N., & Yu, C.-H. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.030 · Cited by 108
Zeng, W., Shan, W., Gao, L., Gao, D., Hu, Y. W., Wang, G., Zhang, N., Li, Z., Tian, X., Xu, W. L., et al. (2015) · Scientific Reports · doi:10.1038/srep16013 · Cited by 108
Negative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging
Wang, R.-H., Zhao, T., Cui, K., Hu, G., Chen, Q., Chen, W., Wang, X. W., Soto–Gutiérrez, A., Zhao, K., & Deng, C. (2016) · Scientific Reports · doi:10.1038/srep28633 · Cited by 106
Self-citationHuang, K., Du, M., Tan, X., Yang, L., Li, X., Jiang, Y., Wang, C., Zhang, F., Zhu, F., Cheng, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.020 · Cited by 103
Metabolic benefits from Sirt1 and Sirt1 activators
Chaudhary, N., & Pfluger, P. T. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832cdaae · Cited by 100
A Potential Treatment of Non-Alcoholic Fatty Liver Disease with SIRT1 Activators
Çolak, Y., Yeşıl, A., Mutlu, H. H., Çaklılı, Ö. T., Ulaşoğlu, C., Şenateş, E., Takır, M., Köstek, O., Yilmaz, Y. N., Enc, F. Y., et al. (2014) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.233.yck · Cited by 100
Shan, W., Gao, L., Zeng, W., Hu, Y. W., Wang, G., Li, M., Zhou, J., Ma, X., Tian, X., & Yao, J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.196 · Cited by 94
Valdecantos, M. P., Pérez‐Matute, P., González‐Muniesa, P., Prieto-Hontoria, P. L., Moreno-Aliaga, M. J., & Martínez, J. A. (2012) · Obesity · doi:10.1038/oby.2012.32 · Cited by 94
Ding, R., Tian, K., Cao, Y., Bao, J., Wang, M., He, C., Yuanjia, H., Su, H., & Wan, J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf502990n · Cited by 92
Self-citationChoi, Y. H., Bae, J. K., Chae, H., Kim, Y., Yim, S., Han, L., Jang, H. Y., & Chin, Y. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b01637 · Cited by 85
Jin, S. H., Yang, J. H., Shin, B. Y., Seo, K., Shin, S. M., Cho, I. J., & Ki, S. H. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.023 · Cited by 83
Tarantino, G., Finelli, C., Scopacasa, F., Pasanisi, F., Contaldo, F., Capone, D., & Savastano, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/920676 · Cited by 80
Chung, J., Koo, K., Lian, F., Hu, K. Q., Ernst, H., & Wang, X. (2012) · Journal of Nutrition · doi:10.3945/jn.111.150052 · Cited by 80
Zhang, P., Qiang, X., Zhang, M., Ma, D., Zhao, Z., Zhou, C., Liu, X., Li, R., Chen, H., & Zhang, Y. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219832 · Cited by 78
Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway
Gao, F., Deng, G., Liu, W., Zhou, K., & Li, M. (2017) · Oncology Reports · doi:10.3892/or.2017.5347 · Cited by 76
Zhang, Z.-F., Fan, S., Zheng, Y., Lu, J. L., Wu, D., Shan, Q., & Hu, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.002 · Cited by 75
Marmier, S., Dentin, R., Daujat‐Chavanieu, M., Guillou, H., Bertrand‐Michel, J., Gerbal‐Chaloin, S., Girard, J. R., Lotersztajn, S., & Postic, C. (2015) · Hepatology · doi:10.1002/hep.27778 · Cited by 74
The role of sirtuins in Alzheimer's disease
Lalla, R., & Dönmez, G. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00016 · Cited by 72
Molecular Links between Caloric Restriction and Sir2/SIRT1 Activation
Wang, Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.321 · Cited by 69
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome
Aroor, A. R., Mandavia, C. H., Ren, J. T., Sowers, J. R., & Pulakat, L. (2012) · Cardiorenal Medicine · doi:10.1159/000335675 · Cited by 67
Kemper, J. K., Choi, S.-E., & Kim, D.-H. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00016-x · Cited by 66
Everitt, H., Hu, M., Ajmo, J. M., Rogers, C. Q., Liang, X., Zhang, R., Yin, H., Choi, A., Bennett, E. S., & You, M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00309.2012 · Cited by 64
Zhang, N., Hu, Y. W., Ding, C., Zeng, W., Shan, W., Fan, H. J., Zhao, Y., Shi, X., Gao, L., Xu, T., et al. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.12.010 · Cited by 64
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
Castaño, D., Larequi, E., Belza, I., Astudillo, A. M., Martínez‐Ansó, E., Balsinde, J., Argemí, J., Aragón, T., Moreno-Aliaga, M. J., Muntané, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.012 · Cited by 62
Sakthisekaran, D. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.555 · Cited by 61
The sirtuin class of histone deacetylases: Regulation and roles in lipid metabolism
Fiorino, E., Giudici, M., Ferrari, A., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2014) · IUBMB Life · doi:10.1002/iub.1246 · Cited by 55
Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis
Lee, J., Hong, S., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S. W., & Lee, W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.011 · Cited by 52
The role of redox changes in oxygen sensing
Weir, Ε. K., & Archer, S. L. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.08.015 · Cited by 51
Effect of alcohol on adipose tissue: a review on ethanol mediated adipose tissue injury
Kema, V. H., Mojerla, N. R., Khan, I., & Mandal, P. (2015) · Adipocyte · doi:10.1080/21623945.2015.1017170 · Cited by 50
Myeloid SIRT1 regulates macrophage infiltration and insulin sensitivity in mice fed a high-fat diet
Ka, S., Song, M., Bae, E. J., & Park, B. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0527 · Cited by 50
SIRT1 Deacetylates TopBP1 and Modulates Intra-S-Phase Checkpoint and DNA Replication Origin Firing
Wang, R., Lahusen, T. J., Chen, Q., Xu, X., Jenkins, L. M. M., Leo, E., Fu, H., Aladjem, M. I., Pommier, Y. G., Appella, E., et al. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.11066 · Cited by 49
Self-citationChoi, Y., Yanagawa, Y., Kim, S., & Park, T. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.11.007 · Cited by 48
SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids
Tobita, T., Guzman‐Lepe, J., Takeishi, K., Nakao, T., Wang, Y., Meng, F., Deng, C., de l’Hortet, A. C., & Soto–Gutiérrez, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149344 · Cited by 47
Self-citationLiu, X., Gao, Y., Li, M., Geng, C., Xu, H. C., Yang, Y., Guo, Y., Jiao, T., Fang, F., & Chang, Y. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.018 · Cited by 46
Emerging Role of Redox Dysregulation in Alcoholic and Nonalcoholic Fatty Liver Disease
Feldstein, A. E., & Bailey, S. M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3897 · Cited by 45
Xu, C., Bai, B., Fan, P., Cai, Y., Huang, B., Law, I. K. M., Liu, L., Xu, A., Tung, C., Li, X., et al. (2013) · Europe PMC (PubMed Central) · Cited by 42
Feige, J. N., Lagouge, M., Cantó, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P., Mataki, C., Elliott, P. J., & Auwerx, J. H. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.005 · Cited by 39
Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review
Pulla, V. K., Battu, M. B., Alvala, M., Sriram, D., & Yogeeswari, P. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.703656 · Cited by 38
Shin, S. Y., Kim, T. H., Wu, H., Choi, Y. H., & Kim, S. G. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.035 · Cited by 36
Guclu, A., Erdur, F., & Türkmen, K. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1565067 · Cited by 33
Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma
Park, S., Lim, J., Kim, J. R., & Cho, S. (2017) · Journal of Veterinary Science · doi:10.4142/jvs.2017.18.4.419 · Cited by 29
SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease
Cho, E.-H. (2014) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2014.4.2.80 · Cited by 27
Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury
Zhang, Y., Wang, C., Tian, Y., Zhang, F., Xu, W., Li, X., Shu, Z., Wang, Y., Huang, K., & Huang, D. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.08.016 · Cited by 26
Walker, A. K., & Näär, A. M. (2012) · Clinical Lipidology · doi:10.2217/clp.11.67 · Cited by 25
Zhang, X., Yu, H., Xiong, Y., Ma, S.-T., Zhao, L., & She, S.-F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011940 · Cited by 24
Park, E. J., Kim, Y. M., Kim, H. J., Jang, S.-Y., Oh, M. H., Lee, D., & Chang, K. C. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.040 · Cited by 22
Kim, K. E., Kim, H., Heo, R. W., Shin, H. J., Yi, C.-O., Lee, D. H., Kim, H. J., Kang, S. S., Cho, G. J., Choi, W. S., et al. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2015.19.5.451 · Cited by 21
Li, M., Guo, K., Vanella, L., Taketani, S., Adachi, Y., & Ikehara, S. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10809 · Cited by 19
Jeon, B. T., Kim, K. E., Heo, R. W., Shin, H. J., Yi, C., Hah, Y., Kim, W., Lee, S., & Roh, G. S. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9542-3 · Cited by 18
Resveratrol Alleviates Ethanol-Induced Hormonal and Metabolic Disturbances in the Rat
Szkudelska, K., Deniziak, M., ROŚ, P., Gwóźdź, K., & Szkudelski, T. (2017) · Physiological Research · doi:10.33549/physiolres.933335 · Cited by 7
Cited by
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Masarone, M., Rosato, V., Dallio, M., Gravina, A. G., Aglitti, A., Loguercio, C., Federico, A., & Persico, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9547613 · Cited by 648
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353
LeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05061-7 · Cited by 202
Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe−/−mice: role of SIRT1
Hua, Y. Q., Zeng, Y., Xu, J., & Xu, X. L. (2021) · Phytomedicine · doi:10.1016/j.phymed.2020.153412 · Cited by 137
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Soret, P.-A., Magusto, J., Housset, C., & Gautheron, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010036 · Cited by 121
Metadata
- Authors
- Ding, R.-B., Bao, J., & Deng, C.-X.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 13
- Issue
- 7
- Pages
- 852-867
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2741636306
- Cited by
- 359
- References
- 177
- FWCI
- 13.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.